Dawes Fretzin Clinical Research Group, LLC

Summary

Dawes Fretzin Clinical Research Group, LLC is a medical facility located in Indianapolis, Indiana. This center is recognized for care of Atopic Dermatitis, Psoriasis, Plaque Psoriasis, Medical Device Dermatitis, Alopecia Areata and other specialties. Dawes Fretzin Clinical Research Group, LLC is involved with conducting 141 clinical trials across 93 conditions. There are 4 research doctors associated with this hospital, such as Scott Fretzin, Kenneth W Dawes, Scott Alfred Fretzin, and John S Barbieri, MD, MBA.

Top PIs

Clinical Trials running at Dawes Fretzin Clinical Research Group, LLC

Atopic Dermatitis

Chronic Urticaria

Alopecia Areata

Psoriasis

Medical Device Dermatitis

Hidradenitis Suppurativa

Injection Site Itch

Obesity

Baldness

Plaque Psoriasis

Lebrikizumab

for Eczema

The purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema (atopic dermatitis), but these places may be very itchy. Participation in this study will last up to approximately 38 weeks (9 and a half months) including 24 weeks (6 months) of treatment.

Recruiting

3 awards

Phase 4

2 criteria

Abrocitinib

for Eczema

This 24-month study will assess the long-term safety and efficacy of liquid abrocitinib oral suspension with or without topical medications in children 2 years of age or older with moderate-to-severe atopic dermatitis. The study will enroll two groups: participants who have completed other abrocitinib studies and participants who have never participated in abrocitinib studies.

Recruiting

2 awards

Phase 3

4 criteria

Tapinarof Cream

for Atopic Dermatitis

The purpose of this global Phase 3 clinical study is to investigate the safety and efficacy of tapinarof cream, 1% in participants ages 3 months to 23 months (inclusive) with atopic dermatitis.

Recruiting

2 awards

Phase 3

2 criteria